Loading clinical trials...
Loading clinical trials...
A Phase 2 Study to Assess the Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Conditions
Interventions
SP-002
Vismodegib
Locations
10
United States
Research Site
Phoenix, Arizona, United States
Research Site
Boca Raton, Florida, United States
Research Site
Coral Springs, Florida, United States
Research Site
Cutler Bay, Florida, United States
Research Site
Rockville, Maryland, United States
Research Site
Lee's Summit, Missouri, United States
Start Date
April 9, 2024
Primary Completion Date
September 30, 2026
Completion Date
March 30, 2029
Last Updated
September 20, 2024
NCT07144384
NCT03050268
NCT07182240
NCT06623201
NCT05020912
NCT07010692
Lead Sponsor
Stamford Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions